Leading Edge Treatment for AFib

Dr. Emmanuel Ekanem, a cardiac electrophysiologist with Winchester Cardiology and Vascular Medicine | Valley Health, and colleagues Daniel Alexander, DO, and Todd Teigeler, MD, have been treating patients for about a year with a new generation radiofrequency ablation (RF) catheter for atrial fibrillation (AFib). The high-power, short duration radio frequency (RF) ablation technology significantly reduces procedure times and saline irrigation volume delivered during ablation, which is of particular importance for patients with heart failure. In all, procedures with the new catheter lessen time in the electrophysiology lab and can shorten recovery time, with the potential of limiting damage to surrounding structures. As the prevalence of atrial fibrillation continues to increase with associated adverse events, it is important to leverage leading-edge technologies to address this growing public health issue. Valley Health is proud to offer advanced treatment options using novel technologies as we continue to deliver nationally recognized cardiovascular care for patients in our community.

Emmanuel Ekanem, MD, (featured in the photo) is a cardiac electrophysiologist with board certifications in cardiovascular disease, echocardiography, and internal medicine. He joined Winchester Cardiology and Vascular Medicine | Valley Health from Mount Sinai Hospital in New York, where he completed two years of sub-specialty training in cardiac electrophysiology. Dr Ekanem has been involved in and led global clinical trials with new leading-edge technologies for the management of cardiac arrhythmias. He has a special interest in the management of heart rhythm disorders, including atrial fibrillation, atrial flutter, supraventricular tachycardia (SVT), ventricular tachycardia (VT) and premature ventricular contractions (PVCs), device implantation including defibrillators, transvenous and leadless pacemakers as well as left atrial appendage closure.